Cargando…

Nitric oxide enhancement strategies

It is becoming increasingly clear that many diseases are characterized or associated with perturbations in nitric oxide (NO) production/signaling. Therapeutics or strategies designed to restore normal NO homeostasis will likely have broad application and utility. This highly complex and multistep pa...

Descripción completa

Detalles Bibliográficos
Autor principal: Bryan, Nathan S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137939/
https://www.ncbi.nlm.nih.gov/pubmed/28031863
http://dx.doi.org/10.4155/FSO.15.48
_version_ 1782471986637701120
author Bryan, Nathan S
author_facet Bryan, Nathan S
author_sort Bryan, Nathan S
collection PubMed
description It is becoming increasingly clear that many diseases are characterized or associated with perturbations in nitric oxide (NO) production/signaling. Therapeutics or strategies designed to restore normal NO homeostasis will likely have broad application and utility. This highly complex and multistep pathway for NO production and subsequent target activation provides many steps in the endogenous pathway that may be useful targets for drug development for cardiovascular disease, antimicrobial, cancer, wound healing, etc. This article will summarize known strategies that are currently available or in development for enhancing NO production or availability in the human body. Each strategy will be discussed including exogenous sources of NO, use of precursors to promote NO production and downstream pathways affected by NO production with advantages and disadvantages highlighted for each. Development of NO-based therapeutics is and will continue to be a major focus of biotech, academia as well as pharmaceutical companies. Application of safe and effective strategies will certainly transform health and disease.
format Online
Article
Text
id pubmed-5137939
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Future Science Ltd
record_format MEDLINE/PubMed
spelling pubmed-51379392016-12-28 Nitric oxide enhancement strategies Bryan, Nathan S Future Sci OA Special Report It is becoming increasingly clear that many diseases are characterized or associated with perturbations in nitric oxide (NO) production/signaling. Therapeutics or strategies designed to restore normal NO homeostasis will likely have broad application and utility. This highly complex and multistep pathway for NO production and subsequent target activation provides many steps in the endogenous pathway that may be useful targets for drug development for cardiovascular disease, antimicrobial, cancer, wound healing, etc. This article will summarize known strategies that are currently available or in development for enhancing NO production or availability in the human body. Each strategy will be discussed including exogenous sources of NO, use of precursors to promote NO production and downstream pathways affected by NO production with advantages and disadvantages highlighted for each. Development of NO-based therapeutics is and will continue to be a major focus of biotech, academia as well as pharmaceutical companies. Application of safe and effective strategies will certainly transform health and disease. Future Science Ltd 2015-08-01 /pmc/articles/PMC5137939/ /pubmed/28031863 http://dx.doi.org/10.4155/FSO.15.48 Text en © Nathan S Bryan This work is licensed under a Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/)
spellingShingle Special Report
Bryan, Nathan S
Nitric oxide enhancement strategies
title Nitric oxide enhancement strategies
title_full Nitric oxide enhancement strategies
title_fullStr Nitric oxide enhancement strategies
title_full_unstemmed Nitric oxide enhancement strategies
title_short Nitric oxide enhancement strategies
title_sort nitric oxide enhancement strategies
topic Special Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137939/
https://www.ncbi.nlm.nih.gov/pubmed/28031863
http://dx.doi.org/10.4155/FSO.15.48
work_keys_str_mv AT bryannathans nitricoxideenhancementstrategies